| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.086 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |